자가 조혈모세포 이식환자와 동종 조혈모세포 이식환자의 삶의 질의 비교
Comparison of Quality of Life of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation Recipients
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
The purpose of this study was to compare Quality of life (QOL) in type and time after Hematopoietic stem cell tansplantation (HSCT) for patients with hematologic cancer. Method: This study was cross-sectional. The autologous recipients was 120, the allogeneic recipients was 237. The obtained data were analyzed using T-test, One-way ANOVA, Scheffe’s test. Results: No significant differences were total QOL between the autologous and allogeneic recipients. But the autologous recipients reported better status than the allogeneic recipients in physical domain, especially 1-3 yr after HSCT. There was poorer QOL of 1-3 yr compared to 1 yr after HSCT in physical, psychological and social domain between the two groups. QOL in time after HSCT of the autologous recipients was significance differences in psychological, social domain. And QOL in time after HSCT of the allogeneic recipients was significant differences in physical, psychological and social domain. Conclusions: QOL of recipients undergoing HSCT is recovered beyond 3 yr point. Accordingly, long term care and service is essential to recipients undergoing HSCT. And further studies with a longitudinal design are necessary.
Abstract
The purpose of this study was to compare Quality of life (QOL) in type and time after Hematopoietic stem cell tansplantation (HSCT) for patients with hematologic cancer. Method: This study was cross-sectional. The autologous recipients was 120, the allogeneic recipients was 237. The obtained data were analyzed using T-test, One-way ANOVA, Scheffe’s test. Results: No significant differences were total QOL between the autologous and allogeneic recipients. But the autologous recipients reported better status than the allogeneic recipients in physical domain, especially 1-3 yr after HSCT. There was poorer QOL of 1-3 yr compared to 1 yr after HSCT in physical, psychological and social domain between the two groups. QOL in time after HSCT of the autologous recipients was significance differences in psychological, social domain. And QOL in time after HSCT of the allogeneic recipients was significant differences in physical, psychological and social domain. Conclusions: QOL of recipients undergoing HSCT is recovered beyond 3 yr point. Accordingly, long term care and service is essential to recipients undergoing HSCT. And further studies with a longitudinal design are necessary.
참고문헌 (21)
- Andrykowski MA, "Quality of life following bone marrow transplantation: findings from a multicenter study", Br J Cancer, 71, pp.1322~1329 (1995)
- Andrykowski MA, "Physical and psychosocial functioning of adult survivors of allogeneic bone marrow transplantation", Bone Marrow Transplant, 4, pp.75~81 (1989)
- Belec RH, "Quality of life: perceptions of long-term survivors of bone marrow transplantation", Oncol Nurs Forum, 19, pp.31~37 (1992)
- Bok JN, "Quality of life and family burden in hematopoietic stem cell transplantation recipients", 석사, pp.2003
- Buchsel PC, "Delayed complications of bone marrow transplantation: an update", Oncol Nurs Forum, 23, pp.1267~1291 (1996)
- Byar KL, "Quality of life 5 or more years postautologous hematopoietic stem cell transplant", Cancer Nurs, 28, pp.148~157 (2005)
- Ferrell BR, "Quality of life as an outcome variable in the management of cancer pain", Cancer, 63, pp.2321~2327 (1989)
- Heinonen H, "Quality of life and factors related to perceived satisfaction with quality of life after allogeneic bone marrow transplantation", Ann Hematol, 80, pp.137~143 (2001)
- Kim SJ, "Quality of life in survivors of allogeneic hematopoietic stem cell transplantation", 석사, pp.2002
- Kim SY, "The development of Korean health related quality of life scale", J Korean Acad Fam Med, 21, pp.382~394 (2000)
- Kim KS, "Status of hematopoietic stem cell tramsplamtation in Korea", J Korean Hematopoietic Stem Cell Transplantation Nurses, 7, pp.9~19 (2005)
- Lee SG, "An methodology research of the quality of life of the allogenic bone marrow transplantation survivors", 석사, pp.2001
- Molassiotis A, "Comparison of the overall quality of life in 50 long-term survivors of autologous and allogeneic bone marrow transplantation", J Adv Nurs, 22, pp.509~516 (1995)
- Molassiotis A, "Quality of life in patients with chronic myeloid leukemia after unrelated donor bone marrow transplantation", Cancer Nurs, 22, pp.340~349 (1999)
- Saleh US, "Quality of life one year following bone marrow transplantation: psychometric evaluation of the quality of life in bone marrow transplant survivors tool", Oncol Nurs Forum, 28, pp.1457~1464 (2001)
- Sutherland HJ, "Quality of life following bone marrow transplantation: a comparison of patient reports with population norms", Bone Marrow Transplant, 19, pp.1129~1136 (1997)
- Watson M, "Goldstone AH, Rees JK, et al. Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukemia patients: analysis of the UK Medical Research Council AML 10 trial", Eur J Cancer, 40, pp.971~978 (2004)
- Whedon M, "Quality of life in adult bone marrow transplant patients: beyond the first year", Semin Oncol Nurs, 10, pp.42~57 (1994)
- Whedon M, "Quality of life of long-term adult survivors of autologous bone marrow transplantation", Oncol Nurs Forum, 22, pp.1527~1537 (1995)
- Winer EP, "Quality of life in patients surviving at least 12 months following high dose chemotherapy with autologous bone marrow support", Psychooncology, 8, pp.167~176 (1999)
- Wolcott DL, "Adaptation of adult bone marrow transplant recipient long-term survivors", Transplantation, 41, pp.478~484 (1986)